Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B
Status:
Completed
Trial end date:
2012-09-10
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe and Asia. The aim of this clinical trial is to investigate
the safety, pharmacokinetics (how the trial drug is distributed in the body) and
pharmacodynamics (physiological effects of the drug on the body) of NNC 0172-0000-2021
administered intravenously and subcutaneously to healthy male subjects and subjects with
haemophilia A or B